Pseudomonas aeruginosa protease IV: A corneal virulence factor of low immunogenicity

Ocular Immunology and Inflammation

Volumn 13, Issue 2-3, 2005, Pages 169-182

  Thibodeaux, Brett A ^a   Caballero, Armando R ^a   Dajcs, Joseph J ^a   Marquart, Mary E ^a   Engel, Lee S ^a   O'Callaghan, Richard J ^a,b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LSU EYE CENTER   (United States)

Author keywords

Antibody; Keratitis; Proteinases; Pseudomonas aeruginosa

Indexed keywords

IMMUNOGLOBULIN G; PROTEASE IV; PROTEINASE; RECOMBINANT ENZYME; UNCLASSIFIED DRUG; VIRUS ENZYME; BACTERIUM ANTIBODY; PEPTIDE HYDROLASE; RECOMBINANT PROTEIN; VIRULENCE FACTOR;

AMINO TERMINAL SEQUENCE; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; COLORIMETRY; CONTROLLED STUDY; CORNEA INJURY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; KERATITIS; MICROBIAL ACTIVITY; NONHUMAN; PROTEIN DEGRADATION; PSEUDOMONAS AERUGINOSA; RABBIT; SLIT LAMP; VIRUS LOAD; WESTERN BLOTTING; ANIMAL; BACTERIAL COUNT; BACTERIAL EYE INFECTION; BIOSYNTHESIS; DISEASE MODEL; ENZYMOLOGY; GRAM NEGATIVE INFECTION; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; IN VITRO STUDY; METHODOLOGY; PATHOGENICITY; PATHOLOGY; TREATMENT OUTCOME;

ANIMALS; ANTIBODIES, BACTERIAL; BLOTTING, WESTERN; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE INFECTIONS, BACTERIAL; IMMUNIZATION; KERATITIS; PEPTIDE HYDROLASES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RABBITS; RECOMBINANT PROTEINS; TREATMENT OUTCOME; VIRULENCE FACTORS;

EID: 25144513638     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.1080/09273940490518937     Document Type: Article

References (40)

1. Sweeney DF, Stapleton F, Leitch C, Taylor J, Holden BA, Willcox MD. Microbial colonization of soft contact lenses over time. Optom Vis Sci. 2001;78:100-105.
2. Stapleton F, Dart JK, Seal DV, Matheson M. Epidemiology of Pseudomonas aeruginosa keratitis in contact lens wearers. Epidemiol Infect. 1995;114:395-402.
3. Alfonso E, Mandelbaum S, Fox MJ, Forster RK. Ulcerative keratitis associated with contact lens wear. Am J Ophthalmol. 1986;101:429-433.
4. Dart JK. Predisposing factors in microbial keratitis: the significance of contact lens wear. Br J Ophthalmol. 1988;72:926-930.
5. Arffa RC, Eve FR. Systemic associations of corneal deposits. Int Ophthalmol Clin. 1991;31:89-110.
6. Twining SS, Krishner SE, Mahnke LA, Frank DA. Effect of Pseudomonas aeruginosa elastase, alkaline protease, and exotoxin A on corneal proteinases and proteins. Invest Ophthalmol Vis Sci. 1993;34:2699-2712.
7. O'Callaghan RJ. Role of exoproteins in bacterial keratitis. Cornea. 1999;8:532-537.
8. Mallari PL, McCarty DJ, Daniell M, Taylor H. Increased incidence of corneal perforation after topical fluoroquinolone treatment for microbial keratitis. Am J Ophthalmol. 2001;131:131-133.
9. Fleiszig SM, Wiener-Kronish JP, Miyazaki H, et al. Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S. Infect Immun. 1997;65:579-586.
10. Cowell BA, Chen DY, Frank DW, Vallis AJ, Fleiszig SM. ExoT of cytotoxic Pseudomonas aeruginosa prevents uptake by corneal epithelial cells. Infect Immun. 1995;63:4072-4077.
11. Estrellas JR PS, Alionte LG, Hobden JA. A Pseudomonas aeruginosa strain isolated from a contact lens-induced acute red eye (CLARE) is protease-deficient. Curr Eye Res. 2000;20:157-165.
12. Liu PV. Extracellular toxins of Pseudomonas aeruginosa. J Infect Dis. 1974;130:94-99.
13. Hobden JA. Pseudomonas aeruginosa proteases and corneal virulence. DNA Cell Biol. 2002;21:391-396.
14. Galloway DR. Pseudomonas aeruginosa elastase and elastolysis revisited: recent developments. Mol Microbiol. 1991;5:2315-2321.
15. Kessler E, Safrin M, Olson JC, Ohman DE. Secreted LasA of Pseudomonas aeruginosa is a staphylolytic protease. J Biol Chem. 1993;268:7503-7508.
16. Park S, Galloway DR. Purification and characterization of LasD: a second staphylolytic proteinase produced by Pseudomonas aeruginosa. Mol Microbiol. 1995;16:263-270.
17. O'Callaghan RJ, Engel LS, Hobden JA, Callegan MC, Green LC, Hill JM. Pseudomonas keratitis: the role of an uncharacterized exoprotein, protease IV, in corneal virulence. Invest Ophthalmol Vis Sci. 1996;37:534-543.
18. Engel LS, Hill JM, Caballero AR, Green LC, O'Callaghan RJ. Protease IV, a unique extracellular protease and virulence factor from Pseudomonas aeruginosa. J Biol Chem. 1998;273:16792-16797.
19. Traidej M, Marquart ME, Caballero AR, Thibodeaux BA, O'Callaghan RJ. Identification of the active site residues of Pseudomonas aeruginosa protease IV. J Biol Chem. 2003;278:2549-2553.
20. Traidej M, Caballero AR, Marquart ME, Thibodeaux BA, O'Callaghan RJ. Molecular analysis of Pseudomonas aeruginosa protease IV expressed in Pseudomonas putida. Invest Ophthalmol Vis Sci. 2002;44:190-196.
21. Caballero AR, Moreau JM, Engel LS, Marquart ME, Hill JM, O'Callaghan RJ. Pseudomonas aeruginosa protease IV enzyme assays and comparison to other Pseudomonas proteases. Anal Biochem. 2001;290:330-337.
22. Steuhl KP, Doring G, Henni A, Thiel HJ, Botzenhart K. Relevance of host-derived and bacterial factors in Pseudomonas aeruginosa corneal infections. Invest Ophthalmol Vis Sci. 1987;28:1559-1568.
23. Caballero A, Thibodeaux B, Marquart M, Traidej M, O'Callaghan RJ. Pseudomonas keratitis: protease IV gene conservation, distribution, and production relative to virulence and other Pseudomonas proteases. Invest Ophthalmol Vis Sci. 2004;45:522-530.
24. Kernacki KA, Hobden JA, Hazlett LD, Fridman R, Berk RS. In vivo bacterial protease production during Pseudomonas aeruginosa corneal infection. Invest Ophthalmol Vis Sci. 1995;36:1371-1378.
25. Hume EBH, Dajcs JJ, Moreau JM, O'Callaghan RJ. Immunization with alpha-toxin toxoid protects the cornea against tissue damage during experimental Staphylococcus aureus keratitis. Infect Immun. 2000;68:6052-6055.
26. Ohman DE, Cryz SJ, Iglewski BH. Isolation and characterization of Pseudomonas aeruginosa PAO mutant that produces altered elastase. J Bacteriol. 1980;142:836-842.
27. Harlow E, Lane D. Using antibodies: a laboratory manual. New York, NY: Cold Spring Harbor Laboratory Press, 1999; 74-76.
28. Engel LS, Hobden JA, Moreau JM, Callegan MC, Hill JM, O'Callaghan RJ. Pseudomonas deficient in protease IV has significantly reduced corneal virulence. Invest Ophthalmol Vis Sci. 1997;38:1535-1542.
29. Menge AC, Michalek SM, Russell MW, Mestecky J. Immune response of the female rat genital tract after oral and local immunization with keyhole limpet hemocyanin conjugated to the cholera toxin B subunit. Infect Immun. 1993;61:2162-2171.
30. Guex N, Diemand A, Peitsch MC. Protein modeling for all. Trends Biochem Sci. 1999;24:364-367.
31. Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis. 1997;18:2714-2723.
32. Peitsch MC. Protein modeling by e-mail. Bio/Technology. 1995;13:658-660.
33. Kolaskar AS, Tongaonkar PC. A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett. 1990;276:172-174.
34. Parker JMR, Guo D, Hodges RS. New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites. Biochemistry. 1986;25:5425-5432.
35. Harlow E, Lane D. Antibodies: a laboratory manual. New York, NY: Cold Spring Harbor Laboratory Press; 1988; 100-101.
36. Bouza E, Garcia-Garrote F, Cercenado E, et al. Pseudomonas aeruginosa: a multicenter study in 136 hospitals in Spain. Rev Esp Quimioter. 2003;16:41-52.
37. Ono Y. Pseudomonas aeruginosa. Nippon Rinsho. 2002;60:2150-2155.
38. Bayston R, Andrews M, Rigg K, Shelton A. Recurrent infection and catheter loss in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int. 1999;19:550-555.
39. Horgan SE, Matheson MM, McLoughlin-Borlace L, Dart JK. Use of a low nutrient culture medium for the identification of bacteria causing severe ocular infection. J Med Microbiol. 1999;48:701-703.
40. Gritz DC, Kwitko S, Trousdale MD, Gonzalez VH, McDonnell PJ. Recurrence of microbial keratitis concomitant with anti-inflammatory treatment in an animal model. Cornea. 1992;11:404-408.